24776621

Georgopoulos NA

2014

Elevated serum androstenedione is associated with a more severe phenotype in women with polycystic ovary syndrome (PCOS).

24777850

de Wilde MA

2014

Preconception predictors of gestational diabetes: a multicentre prospective cohort study on the predominant complication of pregnancy in polycystic ovary syndrome.

24778852

Onofriescu A

2013

GnRH Antagonist IVF Protocol in PCOS.

24782006

Casarini L

2014

Gene polymorphisms in female reproduction.

24783351

Shea JL

2014

Free testosterone: clinical utility and important analytical aspects of measurement.

24786446

Abramson BL

2014

Cardiovascular risk in women: focus on hypertension.

24790517

C?r?k DA

2014

What do we know about metabolic syndrome in adolescents with PCOS?

24791406

Oliver A

2014

Detecting ovarian disorders in primary care.

24791734

Ma J

2014

Gastrointestinal hormones and polycystic ovary syndrome.

24792539

Oncul M

2014

May AMH levels distinguish LOCAH from PCOS among hirsute women?

24793009

Reddy KR

2014

CYP11A1 microsatellite (tttta)n polymorphism in PCOS women from South India.

24796181

Ogueh O

2014

The prevalence of polycystic ovary morphology among women attending a new teaching hospital in southern Nigeria.

24798059

Pasquali R

2014

Reproductive endocrinology: Maternal and fetal insulin levels at birth in women with PCOS.

24799026

Cui Y

2014

Activation of eIF2? signaling cascade is associated with testosterone-induced cell apoptosis in INS-1 cells.

24799558

Boyle JA

2014

Irregular menstrual cycles in a young woman.

24799941

Yu J

2014

Cryptotanshinone Reverses Reproductive and Metabolic Disturbances in PCOS Model Rats via Regulating the Expression of CYP17 and AR.

24802714

Long W

2014

Characterization of serum microRNAs profile of PCOS and identification of novel non-invasive biomarkers.

24803007

Wan HL

2015

Obstetric outcomes in women with polycystic ovary syndrome and isolated polycystic ovaries undergoing in vitro fertilization: a retrospective cohort analysis.

24807336

Camelo Castillo W

2014

Trends in glyburide compared with insulin use for gestational diabetes treatment in the United States, 2000-2011.

24809037

Aquino CI

2014

Complementary therapy in polycystic ovary syndrome.

24811779

Barra R

2014

Maternal sympathetic stress impairs follicular development and puberty of the offspring.

24813197

Ezeh U

2014

Association of fat to lean mass ratio with metabolic dysfunction in women with polycystic ovary syndrome.

24813595

Kort DH

2014

Preliminary evidence that cinnamon improves menstrual cyclicity in women with polycystic ovary syndrome: a randomized controlled trial.

24813752

El Refaeey A

2014

Combined coenzyme Q10 and clomiphene citrate for ovulation induction in clomiphene-citrate-resistant polycystic ovary syndrome.

24814528

Stabile G

2014

Effects of the insulin sensitizer pioglitazone on menstrual irregularity, insulin resistance and hyperandrogenism in young women with polycystic ovary syndrome.

24815492

Lin L

2014

Genetic polymorphisms of TCF7L2 lack influence on risk of the polycystic ovary syndrome - a systemic analysis.

24816317

Willis GR

2014

Detailed characterisation of circulatory nitric oxide and free radical indices--is there evidence for abnormal cardiovascular homeostasis in young women with polycystic ovary syndrome?

24816764

Hung JH

2014

Risk of psychiatric disorders following polycystic ovary syndrome: a nationwide population-based cohort study.

24816947

Ramezani Tehrani F

2014

Comparison of various adiposity indexes in women with polycystic ovary syndrome and normo-ovulatory non-hirsute women: a population-based study.

24819314

G?d?c? N

2014

25-Hydroxyvitamin D levels are related to hyperinsulinemia in polycystic ovary syndrome.

24819317

Bitzer J

2014

Gynecological care in young women: a high-risk period of life.

24821925

Broer SL

2014

Anti-M?llerian hormone: ovarian reserve testing and its potential clinical implications.

24823465

Jensterle M

2014

Phosphodiesterase 4 inhibition as a potential new therapeutic target in obese women with polycystic ovary syndrome.

24823705

Keevil BG

2014

How do we measure hyperandrogenemia in patients with PCOS?

24825080

Eklioglu BS

2014

Aromatase deficiency in an adolescent girl misdiagnosed as congenital adrenal hyperplasia in infancy and childhood.

24825420

Morciano A

2014

Assessment of insulin resistance in lean women with polycystic ovary syndrome.

24826983

Mani H

2014

How to manage an adolescent girl presenting with features of polycystic ovary syndrome (PCOS); an exemplar for adolescent health care in endocrinology.

24828019

Asemi Z

2014

Metabolic response to folate supplementation in overweight women with polycystic ovary syndrome: a randomized double-blind placebo-controlled clinical trial.

24828505

Yin M

2014

Transactivation of micrornA-320 by microRNA-383 regulates granulosa cell functions by targeting E2F1 and SF-1 proteins.

24829217

Yan X

2014

Prenatal androgen excess enhances stimulation of the GNRH pulse in pubertal female rats.

24829532

Singh N

2014

Comparison of gonadotropin-releasing hormone agonist with GnRH antagonist in polycystic ovary syndrome patients undergoing in vitro fertilization cycle: Retrospective analysis from a tertiary center and review of literature.

24829577

Amato MC

2014

Visceral adiposity index: an indicator of adipose tissue dysfunction.

24829583

Nasiri Amiri F

2014

The experience of women affected by polycystic ovary syndrome: a qualitative study from iran.

24830584

Pardini D

2014

Female endocrinology--what is it about?

24830586

Hohl A

2014

Hirsutism: diagnosis and treatment.

24830591

Weiss RV

2014

Female infertility of endocrine origin.

24830592

Costa EM

2014

Effects of endocrine disruptors in the development of the female reproductive tract.

24830595

Spritzer PM

2014

Polycystic ovary syndrome: reviewing diagnosis and management of metabolic disturbances.

24835015

Hikiji W

2014

Sudden death of a middle aged woman with a series of undiagnosed gynaecologic diseases.

24837687

Siristatidis C

2014

Transvaginal ovarian trauma, poor responders and improvement of success rates in IVF: anecdotal data and a hypothesis.

24840107

Carlioglu A

2014

The platelet activating factor acetyl hydrolase, oxidized low-density lipoprotein, paraoxonase 1 and arylesterase levels in treated and untreated patients with polycystic ovary syndrome.

24840109

Kosar O

2014

Luteal phase clomiphene citrate for ovulation induction in women with polycystic ovary syndrome.

24840528

Beckett EM

2014

Developmental programing: impact of testosterone on placental differentiation.

24842895

Ujvari D

2014

Lifestyle intervention up-regulates gene and protein levels of molecules involved in insulin signaling in the endometrium of overweight/obese women with polycystic ovary syndrome.

24842896

Gidwani S

2014

Polycystic ovary syndrome influences the level of serum amyloid A and activity of phospholipid transfer protein in HDL? and HDL?.

24843673

Miyoshi A

2013

Ovarian morphology and prevalence of polycystic ovary syndrome in Japanese women with type 1 diabetes mellitus.

24844662

Sirmans SM

2014

Epidemiology and comorbidities of polycystic ovary syndrome in an indigent population.

24848075

Soave I

2014

Ovarian stimulation in patients in risk of OHSS.

24848079

Shokeir T

2014

The effects of laparoscopic ovarian drilling on flow mediated dilation in women with PCOS: relationship with insulin resistance and IGF-I.

24849376

Sun B

2014

Basal serum testosterone levels correlate with ovarian response but do not predict pregnancy outcome in non-PCOS women undergoing IVF.

24849517

Conway G

2014

The polycystic ovary syndrome: a position statement from the European Society of Endocrinology.

24849592

Shea LD

2014

Bioengineering the ovarian follicle microenvironment.

24851135

Ikeda K

2014

Long-term treatment with dehydroepiandrosterone may lead to follicular atresia through interaction with anti-Mullerian hormone.

24851175

Asgharnia M

2011

The Prevalence of Polycystic Ovary Syndrome (PCOS) in High School Students in Rasht in 2009 According to NIH Criteria.

24851177

Salehpour S

2011

Evaluation of homocysteine levels in patients with polycystic ovarian syndrome.

24852134

Lin M

2014

Evaluation of a levonorgestrel-releasing intrauterine system for treating endometrial hyperplasia in patients with polycystic ovary syndrome.

24855104

Chinnathambi V

2014

Gestational exposure to elevated testosterone levels induces hypertension via heightened vascular angiotensin II type 1 receptor signaling in rats.

24858146

Das RK

2014

Fasting serum glucose and glycosylated hemoglobin level in obesity.

24859501

Patni N

2014

Worsening hypertriglyceridemia with oral contraceptive pills in an adolescent with HIV-associated lipodystrophy: a case report and review of the literature.

24859638

Setji TL

2014

Polycystic ovary syndrome: update on diagnosis and treatment.

24861403

Asnani KP

2014

Expression of nuclear receptors of gingiva in polycystic ovarian syndrome: a preliminary case study.

24861556

Cassina M

2014

First-trimester exposure to metformin and risk of birth defects: a systematic review and meta-analysis.

24864567

Watanabe K

2014

[Adverse events of psychotropic drugs].

24865669

Ryan A

2014

Prolonged gonadotropin stimulation for assisted reproductive technology cycles is associated with decreased pregnancy rates for all women except for women with polycystic ovary syndrome.

24866562

Kuppusamy S

2015

Association of sympathovagal imbalance with cardiovascular risks in patients with polycystic ovary syndrome.

24872311

Cheema BS

2014

Progressive resistance training in polycystic ovary syndrome: can pumping iron improve clinical outcomes?

24872497

Muscogiuri G

2014

Mechanisms in endocrinology: vitamin D as a potential contributor in endocrine health and disease.

24873996

Palomba S

2014

Low-grade chronic inflammation in pregnant women with polycystic ovary syndrome: a prospective controlled clinical study.

24874013

Park J

2014

Finding novel molecular connections between developmental processes and disease.

24875397

Kim JW

2014

Study of circulating hepcidin in association with iron excess, metabolic syndrome, and BMP-6 expression in granulosa cells in women with polycystic ovary syndrome.

24876175

Louwers YV

2014

Excess mortality in mothers of patients with polycystic ovary syndrome.

24877633

Caldwell AS

2014

Characterization of reproductive, metabolic, and endocrine features of polycystic ovary syndrome in female hyperandrogenic mouse models.

24878041

Kobaly K

2014

Parent-of-origin effects on glucose homeostasis in polycystic ovary syndrome.

24881358

Z?rate-Trevi?o A

2014

[Convenience clinic redefine polycystic ovary syndrome (Stein-Leventhal)].

24882164

Mueller SC

2014

Assessing gonadal hormone contributions to affective psychopathologies across humans and animal models.

24883154

de Medeiros SF

2014

Prevalence of elevated glycated hemoglobin concentrations in the polycystic ovary syndrome: anthropometrical and metabolic relationship in amazonian women.

24884959

Pei YJ

2014

Studies of cardiovascular risk factors in polycystic ovary syndrome patients combined with subclinical hypothyroidism.

24885793

Shi Y

2014

Live birth after fresh embryo transfer vs elective embryo cryopreservation/frozen embryo transfer in women with polycystic ovary syndrome undergoing IVF (FreFro-PCOS): study protocol for a multicenter, prospective, randomized controlled clinical trial.

24886252

Caserta D

2014

Bisphenol A and the female reproductive tract: an overview of recent laboratory evidence and epidemiological studies.

24887156

Shao R

2014

Direct effects of metformin in the endometrium: a hypothetical mechanism for the treatment of women with PCOS and endometrial carcinoma.

24889290

Scotti L

2014

Platelet-derived growth factor BB and DD and angiopoietin1 are altered in follicular fluid from polycystic ovary syndrome patients.

24889738

Somani N

2014

Hirsutism: an evidence-based treatment update.

24894925

Shin SH

2014

Idiopathic intracranial hypertension associated with polycystic ovarian syndrome.

24895496

Tock L

2014

Adrenocortical production is associated with higher levels of luteinizing hormone in nonobese women with polycystic ovary syndrome.

24895638

Garruti G

2014

Association between follicular fluid leptin and serum insulin levels in nonoverweight women with polycystic ovary syndrome.

24898132

Fonseca HP

2014

Anti-Mullerian hormone and insulin resistance in polycystic ovary syndrome.

24898153

Unfer V

2014

Updates on the myo-inositol plus D-chiro-inositol combined therapy in polycystic ovary syndrome.

24898321

Moschos E

2015

Prediction of polycystic ovarian syndrome based on ultrasound findings and clinical parameters.

24901345

Kim MJ

2014

Prevalence of metabolic syndrome is higher among non-obese PCOS women with hyperandrogenism and menstrual irregularity in Korea.

24903198

Glintborg D

2014

Prolactin is associated with metabolic risk and cortisol in 1007 women with polycystic ovary syndrome.